Literature DB >> 28306512

An Inflammatory Perspective on Necroptosis.

Conor J Kearney1, Seamus J Martin2.   

Abstract

Necroptosis (programmed necrosis) occurs in response to TNF, Fas, or TRAIL, as well as certain TLR ligands, when caspase activity required for apoptosis is blocked. Necroptosis is typically considered a highly pro-inflammatory mode of cell death, due to release of intracellular "danger signals" that promote inflammation. However, because most pro-necroptotic stimuli are intrinsically highly pro-inflammatory-due to their ability to initiate the synthesis of numerous cytokines and chemokines-the inflammatory consequences of necroptosis are complex. Here, we suggest that necroptosis might have anti-inflammatory effects in certain settings, through curbing excessive TNF- or TLR-induced inflammatory cytokine production.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  apoptosis; cell death; damage-associated molecular patterns; danger; inflammation; necroptosis; necrosis; programmed cell death

Mesh:

Substances:

Year:  2017        PMID: 28306512     DOI: 10.1016/j.molcel.2017.02.024

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  70 in total

Review 1.  Pathways, Contributors, and Correlates of Functional Limitation Across Specialties: Workshop Summary.

Authors:  Stephen B Kritchevsky; Daniel E Forman; Kathryn E Callahan; E Wesley Ely; Kevin P High; Frances McFarland; Eliseo J Pérez-Stable; Kenneth E Schmader; Stephanie A Studenski; John Williams; Susan Zieman; Jack M Guralnik
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2019-03-14       Impact factor: 6.053

2.  Circulating cell death biomarker TRAIL is associated with increased organ dysfunction in sepsis.

Authors:  Edward J Schenck; Kevin C Ma; David R Price; Thomas Nicholson; Clara Oromendia; Eliza Rose Gentzler; Elizabeth Sanchez; Rebecca M Baron; Laura E Fredenburgh; Jin-Won Huh; Ilias I Siempos; Augustine Mk Choi
Journal:  JCI Insight       Date:  2019-05-02

3.  Narciclasine induces autophagy-dependent apoptosis in triple-negative breast cancer cells by regulating the AMPK-ULK1 axis.

Authors:  Chuan Cao; Wei Huang; Nan Zhang; Fengbo Wu; Ting Xu; Xiaoli Pan; Cheng Peng; Bo Han
Journal:  Cell Prolif       Date:  2018-08-28       Impact factor: 6.831

4.  Pannexin-1 limits the production of proinflammatory cytokines during necroptosis.

Authors:  Tiphaine Douanne; Gwennan André-Grégoire; Kilian Trillet; An Thys; Antonin Papin; Magalie Feyeux; Philippe Hulin; David Chiron; Julie Gavard; Nicolas Bidère
Journal:  EMBO Rep       Date:  2019-08-14       Impact factor: 8.807

5.  RIPK3 mediates pathogenesis of experimental ventilator-induced lung injury.

Authors:  Ilias I Siempos; Kevin C Ma; Mitsuru Imamura; Rebecca M Baron; Laura E Fredenburgh; Jin-Won Huh; Jong-Seok Moon; Eli J Finkelsztein; Daniel S Jones; Michael Torres Lizardi; Edward J Schenck; Stefan W Ryter; Kiichi Nakahira; Augustine Mk Choi
Journal:  JCI Insight       Date:  2018-05-03

6.  Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis.

Authors:  Dan E McNamara; Giovanni Quarato; Cliff S Guy; Douglas R Green; Tudor Moldoveanu
Journal:  J Vis Exp       Date:  2018-08-07       Impact factor: 1.355

Review 7.  LAP it up, fuzz ball: a short history of LC3-associated phagocytosis.

Authors:  Jennifer Martinez
Journal:  Curr Opin Immunol       Date:  2018-10-02       Impact factor: 7.486

8.  Gut epithelial TSC1/mTOR controls RIPK3-dependent necroptosis in intestinal inflammation and cancer.

Authors:  Yadong Xie; Yifan Zhao; Lei Shi; Wei Li; Kun Chen; Min Li; Xia Chen; Haiwei Zhang; Tiantian Li; Yu Matsuzawa-Ishimoto; Xiaomin Yao; Dianhui Shao; Zunfu Ke; Jian Li; Yan Chen; Xiaoming Zhang; Jun Cui; Shuzhong Cui; Qibin Leng; Ken Cadwell; Xiaoxia Li; Hong Wei; Haibing Zhang; Huabin Li; Hui Xiao
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

9.  Cell death through the ages: The ICDS 25th Anniversary Meeting.

Authors:  Jarvier N Mohammed; Jesse D Gelles; Camila Rubio-Patiño; Madhavika N Serasinghe; Andrew P Trotta; Richard A Lockshin; Zahra Zakeri; Jerry E Chipuk
Journal:  FEBS J       Date:  2020-03-08       Impact factor: 5.542

Review 10.  Pathogenic mechanisms and the potential of drug therapies for aortic aneurysm.

Authors:  Bo Liu; David J Granville; Jonathan Golledge; Zamaneh Kassiri
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-02-21       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.